![Simon John Peat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Simon John Peat
Fondateur chez Project Better Energy Ltd.
Provenance du réseau au premier degré de Simon John Peat
Entité | Type d'entité | Industrie | |
---|---|---|---|
Se Group Ltd.
![]() Se Group Ltd. Miscellaneous Commercial ServicesCommercial Services SE Group Ltd. is a British company that provides professional, scientific, and technical services. The private company was founded in 2013 and is based in Brighouse, UK.
7
| Private Company | Miscellaneous Commercial Services | 7 |
Project Better Energy Ltd.
![]() Project Better Energy Ltd. Electric UtilitiesUtilities Project Better Energy Ltd. is a British company that generates electric power. The private company is based in Burton-on-Trent, UK. and has subsidiaries in United Kingdom. Project Better Energy was founded in 2012.
2
| Holding Company | Electric Utilities | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Simon John Peat via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
GRESHAM TECHNOLOGIES PLC | Packaged Software | President | |
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Pharmaceuticals: Major | Chairman | |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Biotechnology | Chairman |
Statistiques
Internationale
Royaume-Uni | 3 |
Australie | 2 |
Sectorielle
Health Technology | 3 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 10 |
Chairman | 2 |
President | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Simon John Peat
- Connexions Sociétés